212
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Patients’ Satisfaction with Topical Anti-Glaucoma Medications and Associated Factors at Gondar University Tertiary Eye Care and Training Center, Northwest Ethiopia, 2021

, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 139-146 | Received 06 Mar 2023, Accepted 09 Jun 2023, Published online: 19 Jun 2023

References

  • Chow JT, Hutnik CM, Solo K, Malvankar-Mehta MS. When is evidence enough evidence? A systematic review and meta-analysis of the trabectome as a solo procedure in patients with primary open-angle glaucoma. J Ophthalmol. 2017;2017. doi:10.1155/2017/2965725
  • Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224
  • Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi:10.1016/j.ophtha.2014.05.013
  • Foo VHX, Tan SEM, Chen DZ, et al. Areas and factors associated with patients’ dissatisfaction with glaucoma care. Clin Ophthalmol. 2017;11:1849. doi:10.2147/OPTH.S138668
  • Lemij HG, Hoevenaars JG, van der Windt C, Baudouin C. Patient satisfaction with glaucoma therapy: reality or myth? Clin Ophthalmol. 2015;9:785. doi:10.2147/OPTH.S78918
  • Peterson KM, Huisingh CE, Girkin C, Owsley C, Rhodes LA. Patient satisfaction with care in an urban tertiary referral academic glaucoma clinic in the US. Patient Prefer Adher. 2018;12:775. doi:10.2147/PPA.S162439
  • Stalmans I, Lemij H, Clarke J, Baudouin C, Ophthalmology Gsg JC. Signs and symptoms of ocular surface disease: the reasons for patient dissatisfaction with glaucoma treatments. Clin Ophthalmol. 2020;14:3675. doi:10.2147/OPTH.S269586
  • Kim JM, Kim T-W, Kim CY, Kim HK, Park KH. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients. Japanese J Ophthalmol. 2016;60(1):20–26. doi:10.1007/s10384-015-0420-2
  • Kerr NM, Patel HY, Chew SS, et al. Patient satisfaction with topical ocular hypotensives. Clin Exper Ophthalmol. 2013;41(1):27–35. doi:10.1111/j.1442-9071.2012.02823.x
  • Shikiar R, Rentz AMJVi H. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7(2):204–215. doi:10.1111/j.1524-4733.2004.72252.x
  • Atkinson MJ, Stewart WC, Fain JM, et al. A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP). Health Qual Life Outcomes. 2003;1(1):1–13.
  • Beckers HJ, Schouten JS, Webers CA, van der Valk R, Hendrikse F. Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction. Graefe’s Archiv Clin Exper Ophthalmol. 2008;246(10):1485–1490. doi:10.1007/s00417-008-0875-7
  • Alemu DS, Gudeta AD, Gebreselassie KL. Awareness and knowledge of glaucoma and associated factors among adults: a cross sectional study in Gondar Town, Northwest Ethiopia. BMC Ophthalmol. 2017;17(1):1–12.
  • Assem AS, Fekadu SA, Yigzaw AA, Nigussie ZM, Achamyeleh AA. Level of glaucoma drug adherence and its associated factors among adult glaucoma patients attending Felege Hiwot specialized hospital: Bahir Dar City, Northwest Ethiopia. Clin Optometry. 2020;12:189.
  • Day D, Sharpe E, Atkinson M, Stewart J, Stewart W. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye. 2006;20(5):583–590. doi:10.1038/sj.eye.6701932
  • Ruiz MA, Pardo A, Martinez de la Casa JM, Polo V, Esquiro J, Soto J. Development of a specific questionnaire measuring patient satisfaction with glaucoma treatment: glausat. Ophthalmic Epidemiol. 2010;17(3):131–143.
  • Nordmann J-P, Denis P, Vigneux M, Trudeau E, Guillemin I, Berdeaux G. Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ©) in glaucoma using a qualitative study. BMC Health Serv Res. 2007;7(1):1–9.
  • Kim CY, Park KH, Ahn J, et al. A path analysis of effects of patients’ underlying conditions, treatment satisfaction, and adherence on quality of life among Korea glaucoma patients. J Glaucoma. 2019;28(9):785–789. doi:10.1097/IJG.0000000000001312
  • Van Huy N, Dung NN, Thang CD, Hanh LT. Patient satisfaction with health care services at a national institute of ophthalmology. Int J Health Plan Manag. 2018;33(1):e251–e62. doi:10.1002/hpm.2449
  • Rahmatnejad K, Myers JS, Falls ME, Myers SR, Waisbourd M, Hark LA. Factors associated with patient satisfaction in an outpatient glaucoma population. In: Seminars in Ophthalmology. Taylor & Francis; 2018.
  • Dreer LE, Owsley C, Campbell L, Gao L, Wood A, Girkin CA. Feasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African Americans: “Glaucoma Management Optimism for African Americans Living with Glaucoma”(GOAL). Cur Eye Res. 2016;41(1):50–58. doi:10.3109/02713683.2014.1002045
  • Levy S, Booth A. Patient satisfaction with peninsula optometry community glaucoma scheme. Eye. 2015;29(10):1395. doi:10.1038/eye.2015.67
  • Negrete FJM, Lemij HG, Erb C. Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction. Clinical Ophthalmol. 2017;11:557.
  • Erb C, Stalmans I, Iliev M, Muñoz-Negrete F. Real-world study on patient satisfaction and tolerability after switching to preservative-free latanoprost. Clin Ophthalmol. 2021;15:931. doi:10.2147/OPTH.S295821
  • Wong AB, Wang MT, Liu K, Prime ZJ, Danesh-Meyer HV, Craig JP. Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye. Ocular Surf. 2018;16(3):289–293. doi:10.1016/j.jtos.2018.03.002